Independent biopharmaceutical company Specialised Therapeutics Asia Pte Ltd will partner with Netherlands based biotechnology company Treeway BV to commercialise a new therapy to treat Amyotrophic Lateral Sclerosis – the most common form of Motor Neurone Disease – in Australia and New Zealand.
